These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 21154658)
1. A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine. Bhat SH; Gelhaus SL; Mesaros C; Vachani A; Blair IA Rapid Commun Mass Spectrom; 2011 Jan; 25(1):115-21. PubMed ID: 21154658 [TBL] [Abstract][Full Text] [Related]
2. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions. Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573 [TBL] [Abstract][Full Text] [Related]
3. High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers. Carmella SG; Ming X; Olvera N; Brookmeyer C; Yoder A; Hecht SS Chem Res Toxicol; 2013 Aug; 26(8):1209-17. PubMed ID: 23837805 [TBL] [Abstract][Full Text] [Related]
4. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen. Carmella SG; Borukhova A; Akerkar SA; Hecht SS Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562 [TBL] [Abstract][Full Text] [Related]
5. Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine of nonsmokers and smokers using liquid chromatography/tandem mass spectrometry. Hou H; Zhang X; Tian Y; Tang G; Liu Y; Hu Q J Pharm Biomed Anal; 2012 Apr; 63():17-22. PubMed ID: 22366322 [TBL] [Abstract][Full Text] [Related]
6. Application of an assay for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine for the assessment of tobacco-related harm. Lu W; Ferguson SG; Nichols DS; Patel R; Jacobson GA J Pharm Biomed Anal; 2016 Nov; 131():327-332. PubMed ID: 27632782 [TBL] [Abstract][Full Text] [Related]
7. Development of a rapid method for the simultaneous separation and determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its N- and O-glucuronides in human urine by liquid chromatography-tandem mass spectrometry. Yao L; Zheng S; Guan Y; Yang J; Liu B; Wang W; Zhu X Anal Chim Acta; 2013 Jul; 788():61-7. PubMed ID: 23845482 [TBL] [Abstract][Full Text] [Related]
8. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Carmella SG; Han S; Fristad A; Yang Y; Hecht SS Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1257-61. PubMed ID: 14652291 [TBL] [Abstract][Full Text] [Related]
9. Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL). Ter-Minassian M; Asomaning K; Zhao Y; Chen F; Su L; Carmella SG; Lin X; Hecht SS; Christiani DC Int J Cancer; 2012 Mar; 130(6):1338-46. PubMed ID: 21544809 [TBL] [Abstract][Full Text] [Related]
10. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers. Chen G; Luo S; Kozlovich S; Lazarus P Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298 [TBL] [Abstract][Full Text] [Related]
11. Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk. Chung CJ; Lee HL; Yang HY; Lin P; Pu YS; Shiue HS; Su CT; Hsueh YM Sci Total Environ; 2011 Apr; 409(9):1638-42. PubMed ID: 21334728 [TBL] [Abstract][Full Text] [Related]
12. Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4. Wiener D; Doerge DR; Fang JL; Upadhyaya P; Lazarus P Drug Metab Dispos; 2004 Jan; 32(1):72-9. PubMed ID: 14709623 [TBL] [Abstract][Full Text] [Related]
13. Stability of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine samples stored at various temperatures. Xia Y; Bernert JT J Anal Toxicol; 2010 Sep; 34(7):411-5. PubMed ID: 20822679 [TBL] [Abstract][Full Text] [Related]
14. Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn. Florek E; Piekoszewski W; Basior A; Merritt AT; Mazela J; Lechowicz W; Kornacka MK; Kramer L J Physiol Pharmacol; 2011 Jun; 62(3):377-83. PubMed ID: 21893699 [TBL] [Abstract][Full Text] [Related]
15. Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry. Jacob P; Havel C; Lee DH; Yu L; Eisner MD; Benowitz NL Anal Chem; 2008 Nov; 80(21):8115-21. PubMed ID: 18841944 [TBL] [Abstract][Full Text] [Related]
16. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer. Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261 [TBL] [Abstract][Full Text] [Related]
17. Formation and accumulation of pyridyloxobutyl DNA adducts in F344 rats chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Lao Y; Yu N; Kassie F; Villalta PW; Hecht SS Chem Res Toxicol; 2007 Feb; 20(2):235-45. PubMed ID: 17305407 [TBL] [Abstract][Full Text] [Related]
18. Simple high-throughput analytical method using ultra-performance liquid chromatography coupled with tandem mass spectrometry to quantify total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine. Yang JY; Ahn HK; Lee SW; Han YJ; Oh YJ; Velázquez-Armenta EY; Nava-Ocampo AA Clin Chem Lab Med; 2015 Jul; 53(8):1249-57. PubMed ID: 25720081 [TBL] [Abstract][Full Text] [Related]
19. Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients. Lee HL; Hsueh YM; Chung CJ; Pu YS; Chang LW; Hsieh DP; Liou SH; Lin P Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3390-5. PubMed ID: 19064555 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Xia Y; McGuffey JE; Bhattacharyya S; Sellergren B; Yilmaz E; Wang L; Bernert JT Anal Chem; 2005 Dec; 77(23):7639-45. PubMed ID: 16316171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]